Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Queensland Health
Citi
Johnson and Johnson
Cipla
Farmers Insurance

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 9,078,929

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,078,929
Title:.epsilon.-Polylysine conjugates and the use thereof
Abstract: The present invention relates to .epsilon.-polylysine conjugates, in particular conjugates of .epsilon.-polylysine with compounds carrying carboxyl groups, and to the preparation and use thereof for targeting of the kidney.
Inventor(s): Kuebelbeck; Armin (Bensheim, DE), Larbig; Gregor (Gelnhausen, DE), Mier; Walter (Bensheim, DE), Beijer; Barbro (Nussloch, DE), Haberkorn; Uwe (Schwetzingen, DE)
Assignee: Merck Patent GmbH (Darmstadt, DE)
Application Number:13/384,789
Patent Claims:see list of patent claims

Details for Patent 9,078,929

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Try a Free Trial Merck Patent GmbH (Darmstadt, DE) ➤ Try a Free Trial RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Try a Free Trial Merck Patent GmbH (Darmstadt, DE) ➤ Try a Free Trial RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Try a Free Trial Merck Patent GmbH (Darmstadt, DE) ➤ Try a Free Trial RX Orphan search
Genzyme LEMTRADA alemtuzumab INJECTABLE;INJECTION 103948 003 2001-05-07 ➤ Try a Free Trial Merck Patent GmbH (Darmstadt, DE) ➤ Try a Free Trial RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 002 2001-05-07 ➤ Try a Free Trial Merck Patent GmbH (Darmstadt, DE) ➤ Try a Free Trial RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 001 2001-05-07 ➤ Try a Free Trial Merck Patent GmbH (Darmstadt, DE) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,078,929

Country Patent Number Publication Date
South Africa 201201218 Nov 28, 2012
World Intellectual Property Organization (WIPO) 2011009539 Jan 27, 2011
World Intellectual Property Organization (WIPO) 2011009539 Mar 24, 2011
United States of America 2012122788 May 17, 2012
Slovenia 2456467 Nov 30, 2018
Singapore 10201801503X Apr 27, 2018
Singapore 177629 Mar 29, 2012
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Citi
Mallinckrodt
Chubb
Argus Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.